In recent years, peptidyl arginine deiminase 4 (PAD4) has attracted considerable attention due to the key role it plays in cancer progression and CAT, which affects patient survival and prognosis and has become a potential target for cancer therapy. This evidence concerns the gene PADI4 and cancer.